Patents Assigned to Surface Oncology, Inc.
  • Anti-CD39 antibody compositions and methods
    Patent number: 11655303
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: May 23, 2023
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das, Alison M. O'Neill
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20230042258
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: April 6, 2022
    Publication date: February 9, 2023
    Applicants: Surface Oncology, Inc., Adimab LLC
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY
  • Methods of Treating Cancer with an Anti-CD39 Antibody
    Publication number: 20220389115
    Abstract: The invention provides methods of treating cancer using an anti-CD39 antibody or fragment thereof as monotherapy or in combination with other therapies at particular dosages and frequencies.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 8, 2022
    Applicant: Surface Oncology, Inc.
    Inventors: Andrew Lake, Alison M. O'NEILL, Jou-Ku Chung, Robert Ross
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20220389089
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof at a dose of at least about 0.003 mg/kg to at least about 20 mg/kg.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 8, 2022
    Applicant: Surface Oncology, Inc.
    Inventors: Alison O'NEILL, Lauren HARSHMAN, Jonathan HILL, Jou-Ku CHUNG, Kerry WHITE, Robert ROSS, Benjamin LEE
  • Anti-CD39 Antibody Compositions and Methods
    Publication number: 20220372160
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer. In some embodiments, an isolated anti-CD39 antibody is provided. Such an isolated anti-CD39 antibody binds to human CD39, wherein the antibody is optionally fully human or humanized. In some embodiments, the disclosure provides a method of enhancing, increasing and/or sustaining an anti-tumor immune response in a subject comprising administering the antibody or composition described herein to a subject having a tumor.
    Type: Application
    Filed: September 15, 2020
    Publication date: November 24, 2022
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS, Alison M. O'Neill
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20220259299
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: September 25, 2019
    Publication date: August 18, 2022
    Applicant: SURFACE ONCOLOGY, INC.
    Inventors: Jonathan HILL, Scott CHAPPEL, Michael GLADSTONE, Bianka PRINZ, Andrew LAKE, Christine MILLER, Kerry WHITE, Jing HUA, Pamela M. HOLLAND, Matthew RAUSCH, Devapregasan MOODLEY, Gege TAN
  • Anti-IL-27 antibodies and uses thereof
    Patent number: 11332524
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: May 17, 2022
    Assignees: Surface Oncology, Inc., Adimab LLC
    Inventors: Jonathan Hill, Scott Chappel, Michael Gladstone, Bianka Prinz, Andrew Lake, Christine Miller, Kerry White, Jing Hua, Pamela M. Holland, Matthew Rausch, Devapregasan Moodley
  • Antibody molecules to CD73 and uses thereof
    Patent number: 11312783
    Abstract: Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: April 26, 2022
    Assignees: Novartis AG, SURFACE ONCOLOGY, INC.
    Inventors: Bianka Prinz, Jerry M. Thomas, Ansgar Brock, Scott Chappel, Andrew Lake, Alison Paterson, Rachel W. O'Connor, Michael Warren, Pamela Holland, Dirksen Bussiere, Mikias Woldegiorgis, Wei Shu, John Delmas Venable, Michael Gladstone, Jonathan Hill, Christine Miller
  • Anti-CD112R compositions and methods
    Patent number: 11279758
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: March 22, 2022
    Assignee: Surface Oncology, Inc.
    Inventors: Bianka Prinz, Nadthakarn Boland, Kevin Schutz, John Bukowski, Jennifer Symonds, James Mohan, Marisella Panduro Sicheva
  • Anti-CD112R compositions and methods
    Patent number: 11214619
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: January 4, 2022
    Assignee: SURFACE ONCOLOGY, INC.
    Inventors: Bianka Prinz, Nadthakarn Boland, Kevin Schutz, John Bukowski, Jennifer Symonds, James Mohan, Marisella Panduro Sicheva
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20210363268
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: March 13, 2019
    Publication date: November 25, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Anti-CD112R Compositions and Methods
    Publication number: 20210253699
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Application
    Filed: July 19, 2019
    Publication date: August 19, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Bianka Prinz, Nadthakarn Boland, Kevin Schutz, John Bukowski, Jennifer Symonds, James Mohan, Marisella Panduro Sicheva
  • ANTI-IL-27 ANTIBODIES AND USES THEREOF
    Publication number: 20210115127
    Abstract: The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.
    Type: Application
    Filed: September 25, 2020
    Publication date: April 22, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Jamie STRAND, Jonathan HILL, Devan MOODLEY
  • Anti-CD39 Antibody Compositions and Methods
    Publication number: 20210095041
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.
    Type: Application
    Filed: September 15, 2020
    Publication date: April 1, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS, Alison M. O'Neill
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20200399394
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Antibodies that bind CD39 and uses thereof
    Patent number: 10793637
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: October 6, 2020
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20200277394
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: May 13, 2020
    Publication date: September 3, 2020
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Antibodies that bind CD39 and uses thereof
    Patent number: 10738128
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: August 11, 2020
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das
  • Anti-CD47 antibodies and methods of use
    Patent number: 10570201
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: February 25, 2020
    Assignees: Erasmus University Medical Center, Surface Oncology, Inc.
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • Anti-CD112R Compositions and Methods
    Publication number: 20200040081
    Abstract: The invention provides anti-CD112R antibody compositions and their use in treating cancer.
    Type: Application
    Filed: July 19, 2019
    Publication date: February 6, 2020
    Applicants: Surface Oncology, Inc., Adimab, LLC
    Inventors: Bianka Prinz, Nadthakarn Boland, Kevin Schutz, John Bukowski, Jennifer Symonds, James Mohan, Marisella Panduro Sicheva